This checklist provides a practical framework for applying tiered due diligence to donor relationships. Adopt a unique framework for three levels of risk: Checkpoint (low-risk, local donations) Survey...
This checklist outlines 10 essential questions to ask when evaluating a due diligence vendor. From understanding the sources of data they use and how often it’s updated, to assessing their ability...
Qualify the Right Donors, Minimize Risk, and Maximize Impact Nexis® for Development Professionals has the content and tools you need to streamline your fundraising research, so you can connect with...
The rise of global enforcement actions, ESG mandates, and AI regulations means organizations must rethink how they vet partners, suppliers, and acquisitions. Whether you're entering a new market or...
Led by a team of former government intelligence and law enforcement specialists, ZENRS International offers a variety of security-focused services to clients worldwide. Whether conducting due diligence...
Global organizations need to build the capacity to effectively identify and monitor the most relevant geopolitical and financial trends that could affect their business. Failure to do so may expose them...
Due Diligence
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Patient safety, clinical trial management, mergers and acquisitions, research and development, sales and marketing, and pricing structures are all areas where failure to conduct due diligence and mitigate risk effectively can lead to reputational damage, financial loss, and regulatory enforcement action. In just a couple of decades, the pharmaceuticals and life sciences industry has changed beyond recognition in response to globalization and demand for new products. What does the current risk landscape look like for pharmaceuticals and life sciences sector?